NYSE:ACAArcosa Stock Price, Forecast & News

Arcosa's stock was trading at $37.04 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, ACA stock has increased by 14.4% and is now trading at $42.38.
View which stocks have been most impacted by Coronavirus.

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Arcosa in the last year. There are currently 1 hold rating and 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Arcosa.

Arcosa is scheduled to release its next quarterly earnings announcement on Wednesday, November 4th 2020.
View our earnings forecast for Arcosa.

Arcosa Inc (NYSE:ACA) released its quarterly earnings results on Thursday, July, 30th. The company reported $0.73 EPS for the quarter, topping the consensus estimate of $0.60 by $0.13. The business earned $498.50 million during the quarter, compared to analyst estimates of $498.30 million. Arcosa had a net margin of 6.32% and a return on equity of 6.86%.
View Arcosa's earnings history.

Arcosa declared a quarterly dividend on Tuesday, May 5th. Shareholders of record on Wednesday, July 15th will be given a dividend of $0.05 per share on Friday, July 31st. This represents a $0.20 dividend on an annualized basis and a yield of 0.47%. The ex-dividend date is Tuesday, July 14th.
View Arcosa's dividend history.

4 brokerages have issued twelve-month target prices for Arcosa's stock. Their forecasts range from $48.00 to $61.00. On average, they anticipate Arcosa's share price to reach $53.00 in the next year. This suggests a possible upside of 25.1% from the stock's current price.
View analysts' price targets for Arcosa.

News headlines about ACA stock have trended somewhat negative recently, according to InfoTrie Sentiment. The research firm identifies negative and positive press coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Arcosa earned a media sentiment score of -1.7 on InfoTrie's scale. They also gave press coverage about the company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an effect on the company's share price in the next several days.
View the latest news about Arcosa.

Arcosa saw a decline in short interest in the month of July. As of July 15th, there was short interest totaling 691,400 shares, a decline of 8.1% from the June 30th total of 752,000 shares. Based on an average daily trading volume, of 333,900 shares, the days-to-cover ratio is currently 2.1 days. Currently, 1.5% of the shares of the stock are short sold.
View Arcosa's Current Options Chain.

Some companies that are related to Arcosa include Deere & Company (DE), AGCO (AGCO), Alamo Group (ALG), Lindsay (LNN) and Arts-Way Manufacturing (ARTW).
View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Arcosa investors own include Walt Disney (DIS), AbbVie (ABBV), AT&T (T), NVIDIA (NVDA), Trinity Industries (TRN), Netflix (NFLX), Xilinx (XLNX), Applied Materials (AMAT), Advanced Micro Devices (AMD) and Alibaba Group (BABA).

Arcosa trades on the New York Stock Exchange (NYSE) under the ticker symbol "ACA."

Arcosa's stock is owned by a number of institutional and retail investors. Top institutional investors include Copper Rock Capital Partners LLC (37.27%), Emerald Advisers LLC (0.50%), Emerald Mutual Fund Advisers Trust (0.40%), Dalton Greiner Hartman Maher & Co. (0.40%), Raymond James & Associates (0.29%) and Monarch Partners Asset Management LLC (0.29%). Company insiders that own Arcosa stock include Antonio Carrillo, Kerry S Cole, Ronald J Gafford and Valueact Capital Master Fund,.
View institutional ownership trends for Arcosa.

ACA stock was sold by a variety of institutional investors in the last quarter, including UBS Group AG, First Trust Advisors LP, Raymond James & Associates, Vident Investment Advisory LLC, Vident Investment Advisory LLC, Ziegler Capital Management LLC, Kirr Marbach & Co. LLC IN, and Hennessy Advisors Inc.. Company insiders that have sold Arcosa company stock in the last year include Kerry S Cole, and Ronald J Gafford.
View insider buying and selling activity for Arcosa.

ACA stock was acquired by a variety of institutional investors in the last quarter, including Copper Rock Capital Partners LLC, Dalton Greiner Hartman Maher & Co., Emerald Mutual Fund Advisers Trust, Aptus Capital Advisors LLC, SG Americas Securities LLC, Diversified Trust Co, Alpha Windward LLC, and Sawgrass Asset Management LLC.
View insider buying and selling activity for Arcosa.

Shares of ACA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of ACA stock can currently be purchased for approximately $42.38.

Arcosa has a market capitalization of $2.04 billion and generates $1.74 billion in revenue each year. The company earns $113.30 million in net income (profit) each year or $2.35 on an earnings per share basis. Arcosa employs 6,275 workers across the globe.

The official website for Arcosa is www.arcosa.com.

Arcosa's mailing address is 500 N. Akard Street Suite 400, DALLAS TX, 75201. The company can be reached via phone at 972-942-6500 or via email at [email protected]